Evidence map›Paper›PMID 30925734›Full record

ArticleMaterials (Basel, Switzerland)2019

Potential of Chemical and Physical Enhancers for Transungual Delivery of Amorolfine Hydrochloride.

Indrė Šveikauskaitė, Alius Pockevičius, Vitalis Briedis

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Fractional COLasers in surgery and medicine · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Indrė ŠveikauskaitėDepartment of Clinical Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukilėlių pr. 13, 50161 Kaunas, Lithuania. indre.sveikauskaite@lsmuni.lt.ORCID 0000-0002-6890-3535
Alius PockevičiusDepartment of Veterinary Pathobiology, Lithuanian University of Health Sciences, Tilžės g. 18, 50161 Kaunas, Lithuania. alius.pockevicius@lsmuni.lt.
Vitalis BriedisDepartment of Clinical Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukilėlių pr. 13, 50161 Kaunas, Lithuania. vitalis.briedis@lsmuni.lt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical monotherapy of nail infection is limited by poor drug permeability into the human nail plate. Numerous substances and methods are applied to improve the antifungal agent delivery across the nail plate. This work aimed to evaluate the effect of chemical and physical enhancers on the accumulation and permeation of amorolfine hydrochloride through human nail clippings. Polymeric nail lacquers with Eudragit E100 were developed as a potentially suitable delivery system for amorolfine hydrochloride. Incorporating thioglycolic acid and urea into formulations provided increased accumulation of antifungal agent in nail layers of up to 100% and 57%, respectively. Structural changes of nail barrier, induced by fractional CO₂ laser, were visualized by microscopy. The permeation of amorolfine hydrochloride through the nail increased twofold when thioglycolic acid-containing formulation was applied and the nail was pretreated with a fractional CO₂ laser. The results suggest that this novel combination of enhancers has the potential to be an effective option for topical drug delivery through the nail, and increased the efficacy of treatment.

Indexed as

amorolfine hydrochloridechemical enhancementfractional laseronychomycosispolymeric nail lacquerstransungual delivery

Identifiers

PMID30925734
PMCPMC6480142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.